Favorable Outcomes With Hypomethylating Agents Before Allogeneic Hematopoietic Cell Transplantation in Higher Risk Myelodysplastic Syndrome Patients
Stella Richards DOI: 10.1016/j.clml.2019.03.016 Abstract A groundbreaking study has recently brought forth optimistic findings for patients with…
Read More